Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer

被引：0
|
作者：
Lashen, A. L. [1 ]
Toss, M. T. [1 ]
Fadhil, W. F. [1 ]
Oni, G. O. [1 ]
Madhusudan, S. M. [1 ]
Rakha, E. R. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2023年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [1] Evaluation oncotype DX® 21-gene recurrence score and clinicopathological parameters: a single institutional experience
    Lashen, Ayat
    Toss, Michael S.
    Fadhil, Wakkas
    Oni, Georgette
    Madhusudan, Srinivasan
    Rakha, Emad
    HISTOPATHOLOGY, 2023, 82 (05) : 755 - 766
  • [2] Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer
    Chen, Clara
    Dhanda, Rahul
    Tseng, Wan-Yu
    Forsyth, Michael
    Patt, Debra A.
    JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (04) : 182 - +
  • [3] 21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients
    Chiru, E. D.
    Kuhar, C. Grasic
    Oseledchyk, A.
    Kurzeder, C.
    Vetter, M.
    SWISS MEDICAL WEEKLY, 2022, 152 : 43S - 43S
  • [4] Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting
    Robidoux, A.
    McCullough, D.
    Lau, A.
    Stoppler, M.
    Chao, C.
    BREAST, 2017, 32 : S80 - S80
  • [5] Clinical and pathological factors associated with Oncotype DX® 21-Gene recurrence score in patients diagnosed with early stage breast cancer in a low-middle income country
    Ferreira, Carolina Cavalcanti Goncalves
    Araujo, Julio
    Moreira, Shermann Brandao Rodrigues
    Buzaid, Antonio
    Gagliato, Debora
    CANCER RESEARCH, 2024, 84 (09)
  • [6] Comparison of risk prediction with the 21-gene recurrence score (oncotype DX) and the 70-gene signature (MammaPrint) in patients with estrogen receptor-positive early stage breast cancer
    Jiang, H.
    Denduluri, N.
    Majure, M.
    Favret, A.
    Rugo, H. S.
    CANCER RESEARCH, 2016, 76
  • [7] Use of the Oncotype DX™ 21-Gene Assay to Guide Adjuvant Decision Making in Early-Stage Breast Cancer
    Alison K. Conlin
    Andrew D. Seidman
    Molecular Diagnosis & Therapy, 2007, 11 : 355 - 360
  • [8] Use of the Oncotype DX™ 21-gene assay to guide adjuvant decision making in early-stage breast cancer
    Conlin, Alison K.
    Seidman, Andrew D.
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (06) : 355 - 360
  • [9] Economic impact of 21-gene recurrence score testing on early stage breast cancer in Ireland
    Smyth, L.
    Watson, G.
    Kelly, C. M.
    Keane, M.
    Kennedy, M. J.
    O'Reilly, Seamus
    O'Connor, M.
    Verleger, K.
    O'Reilly, Susan
    Walshe, J. M.
    BREAST, 2015, 24 : S113 - S113
  • [10] Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer
    Yahiya Y. Syed
    Molecular Diagnosis & Therapy, 2020, 24 : 621 - 632
12345